Shape Therapeutics: Funding, Investors & Team (Oct 2026)
Shape Therapeutics’ next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. This is done by redirecting the human cellular machinery already present in our cells, thereby bypassing risks of in vivo immunogenicity and permanent off-target damages commonly associated with CRISPR-based technologies.
Shape Therapeutics has raised $112M across 1 funding round on record, the most recent a Series B of $112M announced in Jul 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Shape Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Shape Therapeutics Funding Rounds
Shape Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Shape Therapeutics Funding Compared to Other Biotechnology Startups
Shape Therapeutics' latest round of $112M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Shape Therapeutics in Biotechnology and Seattle
Companies Similar to Shape Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shape Therapeutics Funding FAQs
What does Shape Therapeutics do?
Shape Therapeutics’ next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. This is done by redirecting the human cellular machinery already present in our cells, thereby bypassing risks of in vivo immunogenicity and permanent off-target damages commonly associated with CRISPR-based technologies.
How much funding has Shape Therapeutics raised?
Shape Therapeutics has raised $112M across 1 round on record. The most recent is a Series B of $112M announced in Jul 2021.
When did Shape Therapeutics last raise funding?
Shape Therapeutics' most recent funding round on record is a Series B of $112M, announced in Jul 2021.
Who is the CEO of Shape Therapeutics?
Francois Vigneault is listed as CEO at Shape Therapeutics.
Where is Shape Therapeutics headquartered?
Shape Therapeutics is based in Seattle, Washington, United States.
How many employees does Shape Therapeutics have?
Shape Therapeutics is in the 51-100 employee band.
How does Shape Therapeutics' funding compare to other Biotechnology startups?
Shape Therapeutics' latest round of $112M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Shape Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Shape Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.